Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.92% to 6,067.70 and the Dow Jones Industrial Average DJIA rising 0.31% to 44,850.35.

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Health-care companies rose sharply amid strong earnings. Elevance Health, the health insurer formerly known as Anthem, posted fourth-quarter profit and revenue ahead of Wall Street targets ...

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.

Elevance Health topped profit and revenue expectations for the fourth quarter and is guiding for more gains from premiums and products in the year ahead. The health insurer formerly known as ...

S&P 500 notches closing record with focus on Trump comments, earnings January 24, 2025 Elevance Health on Thursday ... survey finds The Dow Jones Industrial Average and S&P 500 chalked up record ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow Jones Industrial Average rising 0.

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted quarterly earnings shy of Wall Street expectations.

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to